ROYAL BANK OF CANADA - MYMD PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of MYMD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$7,00011,482
+7076.2%
0.00%
Q2 2023$0
-100.0%
160
-85.1%
0.00%
Q1 2023$2,0001,073
+158.6%
0.00%
Q4 2022$0
-100.0%
415
-82.0%
0.00%
Q3 2022$6,000
+100.0%
2,311
+295.0%
0.00%
Q1 2022$3,0000.0%585
+12.5%
0.00%
Q4 2021$3,000
-57.1%
520
-44.1%
0.00%
Q3 2021$7,0009300.00%
Other shareholders
MYMD PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Praetorian Wealth Management, Inc. 200,000$118,4000.04%
Atlas Brown,Inc. 43,500$25,7520.01%
Taylor & Morgan Wealth Management, LLC 16,086$9,5230.01%
Fidelis Capital Partners, LLC 38,590$22,8450.01%
Cambria Investment Management, L.P. 171,570$101,5690.01%
Corundum Group, Inc. 19,600$11,6030.01%
Bridgecreek Investment Management, LLC 30,000$17,7600.00%
XTX Topco Ltd 39,544$23,4100.00%
WALLED LAKE PLANNING & WEALTH MANAGEMENT, LLC 14,000$8,2880.00%
NWAM LLC 40,000$23,6800.00%
View complete list of MYMD PHARMACEUTICALS INC shareholders